Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
38.41
-0.34 (-0.88%)
Aug 7, 2026, 4:00 PM EDT - Market closed

HRMY Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, HRMY stock has a consensus rating of "Buy" and an average price target of $46.1. The average 1-year stock price forecast is 20.02% higher than the current stock price, while the lowest is $30 (-21.90%) and the highest is $70 (+82.24%).

Price Target: $46.1 (+20.02%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$30$46.1$47.5$70
Change-21.90%+20.02%+23.67%+82.24%

Analyst Ratings

The average analyst rating for HRMY stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingFeb '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy444444
Buy222222
Hold444433
Sell111111
Strong Sell000000
Total111111111010

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Truist Financial
Truist Financial
Hold
Maintains
$29$34
HoldMaintains$29$34-11.48%Aug 5, 2026
Deutsche Bank
Deutsche Bank
Hold
Reiterates
$36$39
HoldReiterates$36$39+1.54%Aug 5, 2026
So Youn Shim
UBS
No rating
UBS
Hold
Maintains
$33$37
HoldMaintains$33$37-3.67%Aug 5, 2026
Bank of America Securities
Bank of America Securities
Sell
Reiterates
$28$30
SellReiterates$28$30-21.90%Aug 5, 2026
Needham
Needham
Buy
Maintains
$45$50
BuyMaintains$45$50+30.17%Aug 4, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
1.03B
from 868.45M
Increased by 19.05%
Revenue Next Year
1.17B
from 1.03B
Increased by 12.97%
EPS This Year
5.22
from 3.60
Increased by 45.05%
EPS Next Year
6.69
from 5.22
Increased by 28.05%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
305.44M437.86M582.02M714.73M868.45M1.03B
Revenue Growth
91.21%43.35%32.93%22.80%21.51%19.05%
Gross Profit
249.92M354.37M460.79M557.92M670.11M784.32M
Gross Margin
81.82%80.93%79.17%78.06%77.16%75.86%
Operating Income
87.53M120.19M192.03M190.83M208.47M299.32M
Net Income
34.60M181.47M128.85M145.49M158.69M235.89M
EPS
----3.605.22
EPS Growth
-----10.89%45.05%
Forward PE
25.2723.0111.1411.8210.057.36
Free Cash Flow
-123.53M72.97M214.83M143.91M211.46M301.60M
No. Analysts
-----10
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High1.0B
Avg1.0B
Low1.0B

Revenue Growth

Revenue Growth202620272028
High
20.0%
Avg
19.0%
Low
17.6%

EPS Forecast

EPS202620272028
High5.31
Avg5.22
Low5.13

EPS Growth

EPS Growth202620272028
High
47.6%
Avg
45.0%
Low
42.5%